Sector Pulse — March 18, 2026

Technology

Theme: AI infrastructure remains the market’s dominant narrative, with spending broadening beyond GPUs into networking, optics, data-center power, memory, design software, and enterprise deployment. At the same time, investors are getting more selective, rewarding execution and monetization while punishing expensive stories with weak visibility, concentration risk, or legal overhangs.

Movers:

NVDA, NVIDIA — Continued to reinforce its role as the core platform provider for the AI stack, extending from chips into networking, software, photonics, and ecosystem partnerships. This matters because NVIDIA is increasingly dictating the pace of capital spending across semis, infrastructure, and cloud, not just participating in it.
MSFT, Microsoft — Deepened its AI and cloud posture through infrastructure, enterprise software integration, and broader platform expansion, but the market is increasingly focused on the strategic importance of the OpenAI relationship. This matters because any change in exclusivity or economics around OpenAI could materially reshape Azure’s AI moat.
GOOGL, Alphabet — Signaled more aggressive AI monetization and pricing power while continuing to integrate Gemini and AI tools across Search, Cloud, and services. The significance is that Alphabet is moving from AI investment mode toward revenue extraction, a key next leg for sentiment.
AMZN, Amazon — Advanced its case as an AI infrastructure and logistics powerhouse via AWS investment, internal delivery expansion, and the prospect of a major OpenAI hosting relationship. This matters because Amazon is trying to convert AI capex intensity into durable cloud share gains and logistics leverage simultaneously.
AVGO, Broadcom — Reinforced its position as a custom silicon and AI networking winner, with growing confidence around outsized AI revenue by 2027. Why it matters: Broadcom is one of the clearest non-NVIDIA beneficiaries of hyperscaler AI spending.
ANET, Arista Networks — Continued to benefit from hyperscaler AI networking demand through 800G switching, liquid-cooled optics, and its “Blue Box” architecture. The broader implication is that Ethernet-based AI networking remains a major secular winner, not a secondary trade.
CIEN, Ciena and GLW, Corning — Both highlighted how optical connectivity is becoming mission-critical AI infrastructure. This matters because the bottleneck in AI is increasingly moving from compute to interconnect, where optical vendors are seeing structural demand acceleration.
MRVL, Marvell — Showed strong hyperscaler and networking positioning, but with a key risk around China revenue deterioration. This matters because AI upside is intact, but geopolitical concentration remains a live valuation constraint.
MU, Micron — Delivered blowout AI memory-driven fundamentals, but the market reaction showed concern that HBM and margin expectations may already be near peak enthusiasm. This matters because Micron has become a proxy for whether AI memory demand can stay supply-constrained and profitable.
TSM, TSMC — Remains the essential manufacturing bottleneck for advanced AI chips, though rising capex and China exposure continue to frame the debate. The significance is clear: TSMC is still the most important non-U.S. asset in the AI supply chain.
ASML, ASML — Reinforced its monopoly status in advanced lithography via the High NA EUV milestone with imec. This matters because ASML remains the irreplaceable capital-equipment gatekeeper for the next generation of AI chips.
AMAT, Applied Materials and LRCX, Lam Research — Both underscored how process equipment vendors are direct beneficiaries of the AI chip buildout, with capital returns and strategic partnerships reinforcing confidence. This matters because wafer fab equipment remains one of the cleaner picks-and-shovels expressions of AI capex.
ARM, Arm Holdings — Continued to gain support around its shift toward merchant CPU design, though governance scrutiny in Malaysia adds noise. Why it matters: Arm is evolving from a licensing story into a more direct participant in AI compute economics.
ORCL, Oracle — Posted one of the market’s more dramatic AI growth stories through a huge backlog and cloud demand, but customer concentration and cash burn are becoming harder to ignore. This matters because Oracle is now a high-beta AI infrastructure trade, not just a legacy enterprise software name.
IBM, IBM — The acquisition of Confluent was a major statement that IBM wants to own real-time enterprise data plumbing for AI, not just sell services around it. This matters because IBM is trying to become indispensable in governed AI deployment for large enterprises.
CRWD, CrowdStrike and PANW, Palo Alto Networks — Security remains tightly tied to AI adoption and geopolitical cyber escalation, but with diverging market risks. CrowdStrike is strengthening its public-sector and AI-security moat; Palo Alto faces a new threat from AI-native offensive security models. The broader takeaway is cybersecurity remains an AI beneficiary, but incumbency is no guarantee of insulation.
SNOW, Snowflake — AI ambition remains high, but legal overhang and monetization questions are now competing with the platform narrative. This matters because Snowflake’s valuation depends on restoring trust in both growth quality and disclosure credibility.
DOCU, DocuSign — Stood out as a quieter enterprise software winner, with IAM scaling and a large buyback reinforcing the shift toward AI-enabled, cash-generative software. This matters because the market is rewarding software names that pair AI optionality with real free cash flow.
FIG, Figma — Strong product and growth momentum are being offset by soaring AI infrastructure costs, making monetization the key debate. Why it matters: Figma is a microcosm of the broader software trade-off between AI adoption and margin preservation.
CDNS, Cadence Design Systems and ALAB, Astera Labs — Both remain tied to AI infrastructure and semiconductor complexity, but are also examples of where valuation is stretched enough that execution misses could be punished severely.
INTC, Intel — Still trying to frame a turnaround around foundry and AI infrastructure relevance, but HBM lag and an overstretched valuation leave little room for error. This matters because Intel remains one of the market’s most fragile AI comeback narratives.
HPE, Hewlett Packard Enterprise — Benefiting from AI server demand, but the market is increasingly frustrated by limited disclosure and weak transparency around AI-specific performance. This matters because hardware stories now need cleaner reporting to sustain re-rating potential.
CHGG, Chegg — Remains a clear casualty of digital disruption, with subscriber and EPS declines confirming a structural rather than cyclical collapse. Why it matters: not all “edtech” survives in an AI-native content environment.

Watch:

OpenAI ecosystem realignment — Any shift involving Microsoft, Amazon, or Oracle and OpenAI relationships could materially reshape AI-cloud market share and investor leadership assumptions.
AI monetization vs. capex discipline — Watch whether software and infrastructure names can prove AI revenue is scaling faster than AI cost inflation, especially for Figma, Snowflake, Oracle, and hardware-heavy enterprise vendors.

Financials

Theme: Financials were defined by a split between capital-markets/wealth winners with structural growth narratives and mounting unease around private credit, legal risk, and balance-sheet transparency. Investors are rewarding firms with clear fee growth, capital return, or strategic expansion, while becoming less tolerant of governance shocks and hidden exposures.

Movers:

AXP, American Express — Continued to differentiate itself through premium pricing power, affluent customer resilience, and aggressive capital return. This matters because AmEx remains one of the cleanest quality-compounder stories in financials, especially if premium travel and fee income stay durable.
SCHW, Charles Schwab — Strengthened its wealth-management and retirement narrative with $1 trillion in IRA assets and upcoming digital retirement tools. The significance is that Schwab keeps proving scale plus platform depth can still win in a crowded advisory market.
MS, Morgan Stanley — Passing the same $1 trillion IRA asset milestone reinforces how sticky retirement and advisory assets are becoming. This matters because wealth management remains one of the market’s favorite fee-based earnings streams inside financials.
IBKR, Interactive Brokers — Continued to outperform the sector as it pairs global market access, digital brokerage scale, and upcoming crypto futures/stablecoin functionality. Why it matters: Interactive Brokers is increasingly a hybrid of traditional brokerage and next-gen trading infrastructure.
HOOD, Robinhood — The launch of Robinhood Ventures Fund I broadened the company’s ambition beyond brokerage into venture exposure and fintech ecosystem building. This matters because Robinhood is trying to become a broader financial platform, but execution risk and valuation sensitivity remain high.
MA, Mastercard and V, Visa — The dominant payment rails are now leaning harder into stablecoins and digital asset infrastructure rather than resisting them. Mastercard’s BVNK deal is a more aggressive reinvention bet; Visa’s stablecoin enablement model is more incremental and lower-risk. This matters because payments incumbents are moving to own the rails of programmable money before challengers do.
INTU, Intuit — The partnership with Circle points to a more serious stablecoin strategy inside mainstream SMB and consumer finance workflows. Why it matters: Intuit is signaling that digital dollars may become part of everyday financial software, not just crypto-native activity.
COIN, Coinbase — Pushed further into the intersection of crypto and AI with AgentKit, but the stock remains highly dependent on narrative follow-through and valuation tolerance. This matters because Coinbase is trying to reframe itself as infrastructure, not just an exchange.
CRCL, Circle — Continued to gain traction as a stablecoin infrastructure winner, with rising institutional validation around Arc and USDC integration. This matters because Circle is becoming one of the clearest public market proxies for regulated digital money adoption.
BLK, BlackRock — The Circle/Arc association and broader fixed-income and blockchain positioning reinforce its role as the institutional bridge between traditional asset management and digital market structure.
SOFI, SoFi — Its push into regulated stablecoins is strategically bold, but that story is being overshadowed by a serious short-seller attack on disclosure and loan accounting. This matters because SoFi’s valuation increasingly depends on trust in the balance sheet, not just product innovation.
PYPL, PayPal — Expanded PYUSD, but legal and operational credibility issues are now overwhelming the fintech innovation story. Why it matters: the market is treating PayPal’s execution problems as more important than its crypto optionality.
JPM, JPMorgan — Still looks structurally strong, but concerns around private credit restrictions, legal exposure, and market stress in adjacent financing channels are becoming more visible. This matters because even the highest-quality balance sheets aren’t immune if private credit cracks widen.
KKR, KKR and BAM, Brookfield Asset Management — Both highlighted how alternative managers are trying to turn infrastructure and climate/AI capex into the next major fee engine. This matters because private capital is moving aggressively toward “real asset” themes linked to power, transit, and AI buildout.
APO, Apollo Global Management — The Epstein-related lawsuit and governance questions stand out as one of the sharpest reputation shocks in the sector. Why it matters: governance risk can overwhelm even large, successful alternatives platforms.
ARES, Ares Management and CG, Carlyle — The market rebound in alternatives was undercut by signs of institutional hedging and private-credit anxiety, particularly around long-dated puts and sector sensitivity. This matters because private markets firms are now trading with greater macro and liquidity sensitivity than investors had assumed.
COF, Capital One — The Hopper travel acquisition looks strategically smart, but the FDIC litigation is a major swing factor. This matters because execution on ecosystem expansion can be drowned out by regulatory and reserve risk.
CB, Chubb and ALL, Allstate — Insurance continues to attract capital as investors favor underwriting discipline, defensiveness, and balance-sheet quality. Chubb benefits from Berkshire’s endorsement; Allstate from upward earnings revisions and value appeal. This matters because quality P&C remains a preferred haven inside financials.
BK, Bank of New York, CME, CME Group, and CBOE, Cboe Global Markets — Market infrastructure names continue to benefit from fee-based defensiveness and market plumbing relevance, especially as volatility and rate expectations stay in focus.
APO, Apollo, WFC, Wells Fargo, LYG, Lloyds, and Gartner-style governance stories in finance-adjacent businesses show that trust and disclosure remain a major differentiator.

Watch:

Private credit stress — Redemption pressure, funding constraints, and hedge activity around alternatives managers and fintech lenders could become a broader valuation headwind for Apollo, Ares, Carlyle, SoFi, and other credit-sensitive names.
Stablecoin adoption by incumbents — Watch whether Visa, Mastercard, Intuit, Robinhood, and SoFi can turn digital-dollar infrastructure from strategy slides into meaningful transaction and fee growth.

Healthcare

Theme: Healthcare is splitting into two camps: innovators with real pipeline or device catalysts and mature operators facing pricing, reimbursement, regulatory, or execution pressure. The strongest stories today were around precision medicine, specialty devices, and home/outpatient care, while drug pricing and legal scrutiny remained key overhangs.

Movers:

JNJ, Johnson & Johnson — The FDA approval of ICOTYDE gave JNJ a significant new growth driver in immunology and reinforced its ability to replenish large franchises through innovation. This matters because JNJ is one of the few mega-cap healthcare names still proving pipeline depth can offset mature-portfolio pressure.
MRK, Merck — Continues to show a credible post-Keytruda diversification path via pipeline and animal health, but investors remain highly focused on whether future launches can meaningfully derisk the patent cliff.
LLY, Eli Lilly and NVO, Novo Nordisk — Obesity and GLP-1 remain huge market opportunities, but sentiment is becoming more two-sided as pricing pressure, policy risk, competition, and market-size assumptions get challenged. This matters because the obesity trade is maturing from pure enthusiasm to more discriminating valuation work.
AMGN, Amgen and GSK, GSK — Participation in politically charged discounted-drug programs is raising broader fears that pricing power could face structural pressure across biopharma, not just isolated headline risk.
PFE, Pfizer — Pipeline progress around oncology is helping the company rebuild its post-COVID identity, and the valuation remains supportive. Why it matters: Pfizer is trying to prove it can become a rerating candidate on pipeline, not just a yield story.
VRTX, Vertex — Benefited from stronger confidence around povetacicept, reinforcing the view that high-quality biotech with visible innovation can still attract capital in a cautious tape.
IONS, Ionis Pharmaceuticals — Entering a catalyst-heavy year with meaningful commercial and regulatory milestones. This matters because Ionis is shifting from “platform promise” to measurable product and pipeline validation.
EXEL, Exelixis — Continued to build credibility as a commercially grounded oncology player, especially as investors search for biotech names with both revenue and pipeline optionality.
GH, Guardant Health and ILMN, Illumina — Precision medicine remains one of healthcare’s strongest structural themes. Guardant is being driven by near-term FDA and commercial catalysts; Illumina by deepening diagnostics partnerships. Why it matters: the market is increasingly rewarding clinical utility and commercial translation, not just sequencing leadership.
ABT, Abbott and DVA, DaVita — Outpatient and home-based care remain durable themes. Abbott is tied to procedural migration and ambulatory care; DaVita is leaning into home kidney-care partnerships. This matters because care delivery is steadily shifting toward lower-cost settings, and device/service incumbents are adjusting accordingly.
ISRG, Intuitive Surgical — Continued to reinforce its dominance in robotic surgery, especially with expansion into ambulatory settings through refurbished systems. This matters because Intuitive is still extending its moat while broadening access points.
MDT, Medtronic — Building momentum across robotic surgery and neurovascular care, with the Scientia Vascular deal adding strategic depth. Why it matters: Medtronic is trying to reposition as a platform innovator rather than a slower-moving diversified medtech.
ENPH, Enphase belongs elsewhere, but MOH, Molina Healthcare, UNH, UnitedHealth, and MOH-type managed care stories show pressure from guidance misses and margin scrutiny. This matters because insurers are being judged much more harshly when execution slips, even if top-line growth remains intact.
COR, Cencora and MCK, McKesson — Distribution and specialty pharma logistics remain relative safe havens, with capital efficiency and GLP-1/specialty exposure driving stronger investor interest.
BIIB, Biogen — Upgraded guidance offered some relief, but the market still wants evidence of durable, non-legacy growth.
CRL, Charles River — The FDA’s push toward non-animal testing methods is a major strategic threat. This matters because entire preclinical business models may need to adapt faster than investors expected.
DGX, Quest Diagnostics — Strong scale remains intact, but margin erosion despite growth is an increasingly visible issue, showing that healthcare services can’t rely on volume alone.

Watch:

Drug pricing policy — Monitor whether moves by Amgen, GSK, and obesity-drug pricing debates broaden into a more systemic industry repricing of long-term margins.
Precision oncology and diagnostics milestones — Upcoming catalysts for Guardant, Illumina, Exelixis, and Ionis could shape where growth capital flows inside healthcare.

Industrials

Theme: Industrials are being driven by a combination of defense modernization, power and grid investment, and selective digital/AI infrastructure exposure. The market is rewarding companies with visible backlog, pricing discipline, and mission-critical positioning, while punishing cyclical names with macro sensitivity or weak momentum.

Movers:

GE, GE Aerospace — Continued to build a strong post-spin story around aerospace, defense, and AI-enabled industrial workflows, though rare-earth supply-chain dependence is becoming a critical strategic risk. This matters because GE Aerospace is no longer just a cyclical aero recovery play; it is increasingly a national-security and advanced manufacturing story.
GEV, GE Vernova — Reinforced its status as a major beneficiary of AI-driven power demand, with strong order growth and rising recognition as a critical provider of grid and generation infrastructure. Why it matters: GE Vernova is becoming one of the clearest industrial winners from the AI power supercycle.
ETN, Eaton — One of the strongest industrial AI beneficiaries, with data-center related order growth validating the thesis that electrical infrastructure is becoming a first-order AI investment theme.
VRT, Vertiv — Further cemented itself as a mission-critical AI infrastructure supplier via record backlog and deep NVIDIA alignment. This matters because Vertiv sits directly at the intersection of power, cooling, and hyperscale AI deployment.
PWR, Quanta Services — Its record backlog and exposure to grid modernization and data-center electrification continue to make it a high-conviction infrastructure name. Why it matters: Quanta remains one of the purest public ways to play real-world AI and power buildout.
JCI, Johnson Controls — The pivot toward AI data-center cooling and digital building systems is gaining credibility, but valuation is stretched. This matters because the market is willing to pay for industrial names with AI infrastructure relevance—up to a point.
BWXT, BWX Technologies and HII, Huntington Ingalls — Defense and nuclear-linked industrials continue to benefit from rising national security spending and strategic reprioritization. This matters because investors are increasingly treating parts of defense and nuclear as structural, not cyclical, themes.
LHX, L3Harris, RTX, RTX, and LMT, Lockheed Martin — Defense technology and sustainment remain in focus, from missile and engine programs to software-centric battlefield modernization. The broader implication is that defense primes with systems integration, software, and autonomy exposure are being revalued for next-generation warfighting relevance.
AXON, Axon Enterprise — Continued to stand out as a software-heavy industrial/public safety compounder, with AI tools like Draft One broadening the company’s moat. This matters because Axon is one of the few industrial-adjacent names getting software-like growth treatment.
BA, Boeing — Commercial weakness and strategic losses to Airbus continue to offset better defense headlines. This matters because Boeing remains one of the clearest examples of an industrial franchise where execution risk still dominates backlog quality.
CAT, Caterpillar and DE, Deere — Both remain fundamentally strong franchises, but the market is demanding more than stability. Caterpillar lacks earnings revision momentum; Deere faces tariff and ag-exposure risks. Why it matters: premium cyclicals need fresh catalysts in this tape.
ATI, ATI Inc. and CRS, Carpenter Technology — Specialty materials names continue to benefit from aerospace, defense, and industrial technology demand, with buybacks and capacity investments reinforcing confidence.
AVAV, AeroVironment and KTOS, Kratos — Defense/drone names remain strategically relevant, but execution and valuation still matter. This matters because the market is willing to fund autonomy and drone narratives, but not without proof of margin discipline.
EME, EMCOR and WCC, Wesco — Quietly benefiting from physical infrastructure, electrification, and data-center buildout, showing that AI exposure is increasingly spreading into old-economy industrial channels.
FAST, Fastenal and LECO, Lincoln Electric — Highlight how valuation and analyst skepticism can still cap enthusiasm even for quality industrial names.

Watch:

Defense software and autonomy procurement — Programs touching L3Harris, RTX, Lockheed, Axon, and drone suppliers could determine which industrial-defense names transition from hardware vendors to system orchestrators.
Power and cooling buildout — Follow Vertiv, Eaton, Johnson Controls, Quanta, and GE Vernova as AI capex increasingly shows up in industrial order books rather than just tech earnings.

Energy

Theme: Energy is being driven by higher oil prices, geopolitical risk, and a growing secondary narrative around AI-driven power demand and LNG/gas infrastructure. The sector’s leadership is broadening: traditional upstream and refining names are benefitting from supply fears, while gas and power-adjacent companies are increasingly tied to data-center and electrification demand.

Movers:

CVX, Chevron — Continued to benefit from higher oil prices and optionality around Venezuela, reinforcing its leverage to geopolitical supply shocks. This matters because Chevron remains one of the cleaner major-oil ways to express “higher-for-longer” crude.
XOM, ExxonMobil — Strength was reinforced indirectly through the exceptional showing from Imperial Oil, highlighting the power of Exxon’s integrated model. Why it matters: Exxon still looks like one of the sector’s most dependable free-cash-flow machines in a volatile macro backdrop.
CNQ, Canadian Natural Resources, EOG, EOG Resources, and FANG, Diamondback Energy — Upstream names continue to be direct beneficiaries of elevated crude prices and supply risk. The broader signal is the market still prefers disciplined producers with strong free-cash-flow torque over more speculative exploration stories.
MPC, Marathon Petroleum and VLO, Valero — Refiners continue to benefit from product pricing and crude volatility. This matters because refining remains one of the strongest cash-flow pockets in energy when geopolitical stress boosts crack spreads.
BKR, Baker Hughes — The Petrobras contract reinforced its success in shifting toward higher-visibility lifecycle and industrial services, rather than just cyclical drilling exposure. Why it matters: Baker Hughes is becoming an energy infrastructure and services compounder, not just a service-cycle trade.
BP, BP — Presented one of the sector’s most bifurcated stories: a major long-cycle offshore win with Kaskida, but also acute labor and refinery risk. This matters because BP is balancing strategic reserve replacement against near-term operational instability.
SHEL, Shell — Continued to reshape itself through portfolio optimization and low-carbon tech positioning, but with real upside tied to carbon capture and e-fuels. This matters because Shell is trying to prove it can remain a capital return story while still building green optionality that investors will value.
TTE, TotalEnergies — Showed how majors are increasingly reallocating away from lower-return hydrocarbon exposure and toward higher-margin assets and energy transition positions. This matters because the market is rewarding companies that are selective, not just expansive, in hydrocarbon capital deployment.
WDS, Woodside Energy and LNG, Cheniere Energy — LNG remains central as Europe and Asia continue to prize supply security. Woodside’s contracts and Cheniere’s strategic relevance reinforce that LNG is both an energy security and geopolitical hedge trade.
DVN, Devon Energy, CTRA, Coterra, NRG, NRG Energy, and TLN, Talen Energy — One of the most important cross-sector themes is the rise of AI-linked gas and power demand. This matters because energy names with direct data-center or hyperscaler exposure are beginning to command a different kind of valuation premium.
ET, Energy Transfer and WMB, Williams — Midstream remains attractive for yield and infrastructure exposure, especially where gas transport links into LNG exports and AI-related power demand.
CF, CF Industries — Showed how fertilizer and ammonia names can also become geopolitical energy proxies when natural gas and shipping lanes tighten. Why it matters: energy security increasingly spills over into chemicals and ag inputs.
ENB, Enbridge, MPLX, MPLX, and BIP, Brookfield Infrastructure Partners tie into the same broader infrastructure theme, though valuation and income trade-offs vary.
UUUU, **Energy Fu